Skip to main content
. 2020 Apr 1;3(4):e201768. doi: 10.1001/jamanetworkopen.2020.1768

Table 2. Final Time-to-Death Model for Developmental Cohort Following Backward Eliminationa.

Variable HR (95% CI)
Year 0 Year 4
Age at index date, centered 1.03 (1.03-1.03) 1.03 (1.03-1.04)
Female 0.87 (0.85-0.89) 0.82 (0.78-0.87)
Cancer typeb
Lung 1 [Reference] 1 [Reference]
Breast 0.33 (0.31-0.34) 0.54 (0.49-0.60)
Colorectal 0.51 (0.50-0.53) 0.73 (0.66-0.81)
Prostate 0.20 (0.19-0.21) 0.45 (0.41-0.51)
Cancer stageb
I 1 [Reference] 1[Reference]
II 1.64 (1.57-1.70) 1.17 (1.08-1.26)
III 2.70 (2.61-2.80) 1.45 (1.34-1.58)
IV 5.05 (4.87-5.23) 1.98 (1.80-2.17)
Admitted to hospital in past 3 mo 1.17 (1.14-1.20) 1.94 (1.83-2.07)
Chronic disease
CHF 1.21 (1.17-1.25) 1.41 (1.32-1.51)
COPD 1.19 (1.16-1.22) 1.38 (1.29-1.47)
Dementia 1.17 (1.11-1.23) 1.63 (1.48-1.79)
Radiation in past 3 mo 1.12 (1.09-1.14) 1.48 (1.36-1.60)
Chemotherapy in past 3 mo 1.06 (1.04-1.08) 2.18 (2.03-2.33)
Surgery for cancer in past 3 mo 0.77 (0.75-0.78) NA
Distance from cancer center ≤50 km 0.92 (0.90-0.93) 0.94 (0.89-0.99)
Pain score
High 1.14 (1.10-1.18) 1.01 (0.90-1.13)
Moderate 1.10 (1.07-1.13) 0.96 (0.87-1.05)
Low 1.04 (1.02-1.07) 1.13 (1.04-1.23)
None 1 [Reference] 1 [Reference]
Well-being score
High 1.15 (1.10-1.19) 1.23 (1.09-1.39)
Moderate 1.09 (1.05-1.13) 1.10 (0.99-1.21)
Low 1.05 (1.02-1.09) 1.01 (0.93-1.10)
None 1 [Reference] 1 [Reference]
Functional scorec
10-30 1.31 (1.23-1.39) 1.19 (1.01-1.40)
40-50 1.30 (1.25-1.35) 1.30 (1.15-1.46)
60-70 1.15 (1.11-1.19) 1.41 (1.27-1.56)
80-90 1.08 (1.05-1.11) 1.35 (1.24-1.47)
100 1 [Reference] 1 [Reference]
Appetite
High, worst appetite 1.36 (1.31-1.41) 1.24 (1.08-1.42)
Moderate 1.22 (1.18-1.26) 1.30 (1.17-1.44)
Low 1.14 (1.11-1.18) 1.16 (1.05-1.27)
No problems, best appetite 1 [Reference] 1 [Reference]
Received home care 1.43 (1.39-1.47) 2.04 (1.87-2.23)
Hospitalized for palliative care 8.00 (7.75-8.26) 17.25 (15.66-19.00)
Resides in long-term care facility 1.58 (1.50-1.67) 1.78 (1.61-1.96)

Abbreviations: CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; HR, hazard ratio; NA, not applicable.

a

A full list of covariates for each model is given in eTable 2 in the Supplement.

b

The HR estimates are from the main effects–only model (without the interaction between cancer type and cancer stage).

c

Functional score ranges from 0 to 100 (in 10-point increments), with 80 to 100 indicating stable, 40 to 70 indicating transitional, 10 to 30 indicating end of life, and 0 indicating dead.